NCT03891823 - Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitation In Heart Failure (The EVOLVE-MR Trial) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 8, 2019

Primary Completion Date

March 28, 2024

Study Completion Date

May 15, 2024

Conditions

Ventricular Remodeling, Left

Interventions

DEVICE

MitraClip

Study participants will be randomized to MitraClip device to determine treatment efficacy in improving LV remodelling or functional capacity.

DRUG

Medical Therapy

Study participants will be randomized to medical therapy to determine treatment efficacy in improving LV remodelling or functional capacity.

Trial Locations (1)

Montreal Heart Institute, Montreal